Expertise

With a successful track record of more than 13 years of clinical trial development and management experience with biotech, pharmaceutical, and medical device companies, Synteract has earned a reputation as a flexible, high quality and responsive company, understanding the distinct challenges inherent in projects that require full attention to detail and complete accuracy of data and documentation. We are adaptive; our full-service capabilities allow us to handle an entire program or simply specific services needed by our drug and device clients, including everything from protocol strategy to regulatory submission.

Emerging Firms

While we continue to expand our services and offices to meet the growing demands of large and international trials, we also maintain a unique specialty in meeting the needs of emerging pharmaceutical, device and biotech firms. As an entrepreneurial company that has grown organically itself, Synteract understands the financial and time constraints that small, mid-sized and emerging companies face. We have developed technology and business process efficiencies that bring projects in on time and within budget. With an insider’s expertise, we guide emerging companies in the clinical trial process, expanding beyond phase I and II trials to the larger requirements of phase III and IV trials.

Therapeutic Specialties

We have broad experience in a wide range of therapeutic areas handling both drug and device trials. In particular, we have an especially strong emphasis in oncology, central nervous system (CNS), cardiovascular disease, and ophthalmology. See our full list of trial types managed here.